1149 related articles for article (PubMed ID: 36634566)
1. Mitochondrial related genome-wide Mendelian randomization identifies putatively causal genes for multiple cancer types.
Li Y; Sundquist K; Zhang N; Wang X; Sundquist J; Memon AA
EBioMedicine; 2023 Feb; 88():104432. PubMed ID: 36634566
[TBL] [Abstract][Full Text] [Related]
2. Assessing the causal role of epigenetic clocks in the development of multiple cancers: a Mendelian randomization study.
Morales Berstein F; McCartney DL; Lu AT; Tsilidis KK; Bouras E; Haycock P; Burrows K; Phipps AI; Buchanan DD; Cheng I; ; Martin RM; Davey Smith G; Relton CL; Horvath S; Marioni RE; Richardson TG; Richmond RC
Elife; 2022 Mar; 11():. PubMed ID: 35346416
[TBL] [Abstract][Full Text] [Related]
3. Identifying actionable druggable targets for breast cancer: Mendelian randomization and population-based analyses.
Zhang N; Li Y; Sundquist J; Sundquist K; Ji J
EBioMedicine; 2023 Dec; 98():104859. PubMed ID: 38251461
[TBL] [Abstract][Full Text] [Related]
4. Circadian clock-related genome-wide mendelian randomization identifies putatively genes for ulcerative colitis and its comorbidity.
Huang M; Wu Y; Li Y; Chen X; Feng J; Li Z; Li J; Chen J; Lu Y; Feng Y
BMC Genomics; 2024 Feb; 25(1):130. PubMed ID: 38302916
[TBL] [Abstract][Full Text] [Related]
5. Prioritizing putative influential genes in cardiovascular disease susceptibility by applying tissue-specific Mendelian randomization.
Taylor K; Davey Smith G; Relton CL; Gaunt TR; Richardson TG
Genome Med; 2019 Jan; 11(1):6. PubMed ID: 30704512
[TBL] [Abstract][Full Text] [Related]
6. Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.
Zhang L; Xiong Y; Zhang J; Feng Y; Xu A
J Transl Med; 2024 Apr; 22(1):330. PubMed ID: 38576019
[TBL] [Abstract][Full Text] [Related]
7. Mendelian randomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer.
Gao C; Patel CJ; Michailidou K; Peters U; Gong J; Schildkraut J; Schumacher FR; Zheng W; Boffetta P; Stucker I; Willett W; Gruber S; Easton DF; Hunter DJ; Sellers TA; Haiman C; Henderson BE; Hung RJ; Amos C; Pierce BL; Lindström S; Kraft P;
Int J Epidemiol; 2016 Jun; 45(3):896-908. PubMed ID: 27427428
[TBL] [Abstract][Full Text] [Related]
8. Causal effect of gut microbiota on pancreatic cancer: A Mendelian randomization and colocalization study.
Li X; Liang Z
J Cell Mol Med; 2024 Apr; 28(8):e18255. PubMed ID: 38526030
[TBL] [Abstract][Full Text] [Related]
9. Multi-omic insight into the molecular networks of mitochondrial dysfunction in the pathogenesis of inflammatory bowel disease.
Chen J; Ruan X; Sun Y; Lu S; Hu S; Yuan S; Li X
EBioMedicine; 2024 Jan; 99():104934. PubMed ID: 38103512
[TBL] [Abstract][Full Text] [Related]
10. Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis.
Yarmolinsky J; Díez-Obrero V; Richardson TG; Pigeyre M; Sjaarda J; Paré G; Walker VM; Vincent EE; Tan VY; Obón-Santacana M; Albanes D; Hampe J; Gsur A; Hampel H; Pai RK; Jenkins M; Gallinger S; Casey G; Zheng W; Amos CI; ; ; ; Smith GD; Martin RM; Moreno V
PLoS Med; 2022 Feb; 19(2):e1003897. PubMed ID: 35113855
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress gene expression, DNA methylation, and gut microbiota interaction trigger Crohn's disease: a multi-omics Mendelian randomization study.
Xu S; Li X; Zhang S; Qi C; Zhang Z; Ma R; Xiang L; Chen L; Zhu Y; Tang C; Bourgonje AR; Li M; He Y; Zeng Z; Hu S; Feng R; Chen M
BMC Med; 2023 May; 21(1):179. PubMed ID: 37170220
[TBL] [Abstract][Full Text] [Related]
12. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.
Yarmolinsky J; Bouras E; Constantinescu A; Burrows K; Bull CJ; Vincent EE; Martin RM; Dimopoulou O; Lewis SJ; Moreno V; Vujkovic M; Chang KM; Voight BF; Tsao PS; Gunter MJ; Hampe J; Pellatt AJ; Pharoah PDP; Schoen RE; Gallinger S; Jenkins MA; Pai RK; ; ; Gill D; Tsilidis KK
Diabetologia; 2023 Aug; 66(8):1481-1500. PubMed ID: 37171501
[TBL] [Abstract][Full Text] [Related]
13. Mendelian randomization analysis identifies druggable genes and drugs repurposing for chronic obstructive pulmonary disease.
Wang Z; Li S; Cai G; Gao Y; Yang H; Li Y; Liang J; Zhang S; Hu J; Zheng J
Front Cell Infect Microbiol; 2024; 14():1386506. PubMed ID: 38660492
[TBL] [Abstract][Full Text] [Related]
14. Drug-target Mendelian randomization revealed a significant association of genetically proxied metformin effects with increased prostate cancer risk.
Sun X; Ping J; Guo X; Long J; Cai Q; Shu XO; Shu X
Mol Carcinog; 2024 May; 63(5):849-858. PubMed ID: 38517045
[TBL] [Abstract][Full Text] [Related]
15. Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis.
Bouras E; Karhunen V; Gill D; Huang J; Haycock PC; Gunter MJ; Johansson M; Brennan P; Key T; Lewis SJ; Martin RM; Murphy N; Platz EA; Travis R; Yarmolinsky J; Zuber V; Martin P; Katsoulis M; Freisling H; Nøst TH; Schulze MB; Dossus L; Hung RJ; Amos CI; Ahola-Olli A; Palaniswamy S; Männikkö M; Auvinen J; Herzig KH; Keinänen-Kiukaanniemi S; Lehtimäki T; Salomaa V; Raitakari O; Salmi M; Jalkanen S; ; Jarvelin MR; Dehghan A; Tsilidis KK
BMC Med; 2022 Jan; 20(1):3. PubMed ID: 35012533
[TBL] [Abstract][Full Text] [Related]
16. Rho GTPase gene expression and breast cancer risk: a Mendelian randomization analysis.
Kazmi N; Robinson T; Zheng J; Kar S; Martin RM; Ridley AJ
Sci Rep; 2022 Jan; 12(1):1463. PubMed ID: 35087170
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota and risk of five common cancers: A univariable and multivariable Mendelian randomization study.
Wei Z; Yang B; Tang T; Xiao Z; Ye F; Li X; Wu S; Huang JG; Jiang S
Cancer Med; 2023 May; 12(9):10393-10405. PubMed ID: 36880394
[TBL] [Abstract][Full Text] [Related]
18. Do sex hormones confound or mediate the effect of chronotype on breast and prostate cancer? A Mendelian randomization study.
Hayes BL; Robinson T; Kar S; Ruth KS; Tsilidis KK; Frayling T; Murray A; Martin RM; Lawlor DA; Richmond RC
PLoS Genet; 2022 Jan; 18(1):e1009887. PubMed ID: 35061662
[TBL] [Abstract][Full Text] [Related]
19. Brain Proteome-Wide and Transcriptome-Wide Asso-ciation Studies, Bayesian Colocalization, and Mendelian Randomization Analyses Reveal Causal Genes of Parkinson's Disease.
Zhou S; Tian Y; Song X; Xiong J; Cheng G
J Gerontol A Biol Sci Med Sci; 2023 Mar; 78(4):563-568. PubMed ID: 36511626
[TBL] [Abstract][Full Text] [Related]
20. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes.
Yang C; Fagan AM; Perrin RJ; Rhinn H; Harari O; Cruchaga C
Genome Med; 2022 Dec; 14(1):140. PubMed ID: 36510323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
